Video streaming giant Netflix, Inc. (NASDAQ: NFLX) is expected to publish its June quarter results today after the closing bell. The market
Netflix Q2 2023 Earnings Call: Listen Live and Follow Along with the Real-Time Transcript
Categories
LATEST
IBM Q2 2023 Earnings Call: Listen Live and Get the Real-Time Transcript
Some of the top companies are scheduled to report earnings today, and International Business Machines Corporation (NYSE: IBM) is one of them.
Tesla Q2 2023 Earnings: Stay tuned for the live earnings call and real-time transcript
Electric vehicle maker Tesla Inc. (NASDAQ: TSLA) will be publishing second-quarter 2023 earnings today at 4:05 pm ET. The company is expected
Ocean Biomedical focuses its malaria program to address chronic malaria crisis in sub-Saharan Africa
Biopharma company Ocean Biomedical, Inc. (NASDAQ: OCEA) on Tuesday said it is focusing its multi-pronged malaria program to address the chronic malaria
We see public listing as the next logical step in our growth as an organization: CEO of Aeries
Aeries Technology is a global services company providing technology, business process management and transformation services to some of the leading global organizations. The
Superlatus names Dr. Eugenio Bortone COO; interim CEO Tim Alford to become CCO
Superlatus, Inc., a holding company of food products and distribution capabilities, on Tuesday, announced new appointments to its management team. The company
Ocean Biomedical (OCEA) joins the Russell 2000 Index
Ocean Biomedical, Inc. (NASDAQ: OCEA) on Tuesday said it has been included in the Russell 2000 Index and the broad-market Russell 3000
Ocean Biomedical granted US patent for bispecific cancer immunotherapy treatment
Biotechnology company Ocean Biomedical, Inc. (NASDAQ: OCEA) on Monday said its scientific co-founder Dr. Jack Elias has been granted a new, broad
Superlatus to be acquired by TRxADE HEALTH to create a global food consolidation platform
Superlatus, Inc., a U.S.-based holding company of food products and distribution capabilities, has signed a letter of intent to be acquired by
Ocean Biomedical extends patent rights for idiopathic pulmonary fibrosis discovery to Europe
Biopharma company Ocean Biomedical, Inc. (NASDAQ: OCEA) on Friday revealed that its scientific co-founder Dr. Jack Elias has received notice from the
Fundamental Research Corp. raises Ocean Biomedical’s price target to $17.63 per share
Ocean Biomedical, Inc. (NASDAQ: OCEA) on Wednesday said that Fundamental Research Corp. increased the price target of the company’s stock to $17.63
Initial response to single-serve pour-over product is the driver behind NuZee’s business: CEO
NuZee, Inc. (NASDAQ: NUZE) is a leading coffee technology and co-packing company that provides end-to-end sustainable solutions for clients ranging from small
Ocean Biomedical’s scientific co-founder Dr. Jonathan Kurtis gets new patent for malaria vaccine
Ocean Biomedical, Inc. (NASDAQ: OCEA), a biopharmaceutical company focused on clinical programs in oncology, fibrosis, and infectious disease, Thursday said its scientific
Taglich Brothers initiates coverage of Ocean Biomedical, with price target of $20
Biopharma company Ocean Biomedical, Inc. (NASDAQ: OCEA) on Thursday revealed that Taglich Brothers initiated coverage on the company with a share price
Ocean Biomedical (OCEA) set to join the Russell 2000 Index
Biopharmaceutical company Ocean Biomedical (NASDAQ: OCEA) on Thursday said it is expected to be added to the Russell 2000 Index, effective after
Ocean Biomedical (OCEA) announces patent award for novel cancer immunotherapy treatment
Biopharma company Ocean Biomedical (NASDAQ: OCEA) on Tuesday said its scientific co-founder Dr. Jack Elias has been issued a broad patent for
Ocean Biomedical announces private placement of $25 mln convertible notes
Biopharma company Ocean Biomedical, Inc. (NASDAQ: OCEA) on Tuesday said it has entered into a private placement pursuant to a securities purchase
MCHP Earnings: Microchip Technology Q4 2023 sales and profit increase
Microchip Technology Inc. (NASDAQ: MCHP) has announced financial results for the fourth quarter of 2023, reporting a 21% growth in net sales.
H&R Block, Inc. (HRB) Q3 2023 Earnings Call Transcript
H&R Block, Inc. (NYSE: HRB) Q3 2023 Earnings Call dated May. 09, 2023 Corporate Participants: Michaella Gallina -- Vice President of Investor
Apple (AAPL) Q2 2023 sales down 3%; results beat estimates
Gadget giant Apple Inc. (NASDAQ: AAPL) on Thursday said its second-quarter 2023 sales declined from last year, reflecting lower Mac and iPad
Advanced Micro Devices sees recovery in second half. Is the stock a buy?
Semiconductor company Advanced Micro Devices, Inc. (NASDAQ: AMD) had an unimpressive start to the new fiscal year, reporting weak numbers for the